Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 2/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | NDUFS8 | O00217 | 2/20 | 0.36 |
| ▸ | COXFA4 | O00483 | 2/20 | 0.36 |
| ▸ | NDUFAB1 | O14561 | 2/20 | 0.36 |
| ▸ | NDUFA1 | O15239 | 2/20 | 0.36 |
| ▸ | NDUFS4 | O43181 | 2/20 | 0.36 |
| ▸ | NDUFB5 | O43674 | 2/20 | 0.36 |
| ▸ | NDUFB3 | O43676 | 2/20 | 0.36 |
| ▸ | NDUFC1 | O43677 | 2/20 | 0.36 |
| ▸ | NDUFA2 | O43678 | 2/20 | 0.36 |
| ▸ | NDUFS5 | O43920 | 2/20 | 0.36 |
| ▸ | NDUFS7 | O75251 | 2/20 | 0.36 |
| ▸ | NDUFS2 | O75306 | 2/20 | 0.36 |
| ▸ | NDUFS6 | O75380 | 2/20 | 0.36 |
| ▸ | NDUFB1 | O75438 | 2/20 | 0.36 |
| ▸ | NDUFS3 | O75489 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2868632 | 1.00 | LSS (0.40) | LSSAOC3KCNA3TDP1L3MBTL1 | |
| SCHEMBL2870332 | 0.79 | LSS (0.49) | LSSTDP1L3MBTL1HTTTRPV1 | |
| SCHEMBL2870331 | 0.79 | LSS (0.49) | LSSTDP1L3MBTL1HTTTRPV1 | |
| SCHEMBL7536951 | 0.78 | TRPV1 (0.56) | TDP1L3MBTL1NDUFS8COXFA4NDUFAB1 | |
| SCHEMBL11757158 | 0.78 | TRPV1 (0.56) | TDP1L3MBTL1NDUFS8COXFA4NDUFAB1 | |
| SCHEMBL2865999 | 0.77 | GPR174 (0.40) | AOC3KCNA3L3MBTL1GPR174ALOX15 | |
| SCHEMBL2865998 | 0.77 | GPR174 (0.40) | AOC3KCNA3L3MBTL1GPR174ALOX15 | |
| SCHEMBL14273810 | 0.76 | PTPN1 (0.57) | TRPV1HPGD | |
| SCHEMBL4762469 | 0.76 | PTPN1 (0.57) | TRPV1HPGD | |
| SCHEMBL11289133 | 0.76 | LTA4H (0.41) | LSSAOC3LMNAALDH1A1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | LSS 1302/4885AOC3 836/4885KCNA3 4074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.